DK0876146T3 - Nucleoside analoger i kombinationsterapi af herpes simplex infektioner - Google Patents

Nucleoside analoger i kombinationsterapi af herpes simplex infektioner

Info

Publication number: DK0876146T3
Authority: DK; Denmark
Prior art keywords: combination therapy; herpes simplex; nucleoside analogues; simplex infections; infections
Prior art date: 1996-01-26

Application number

DK97901694T

Other languages

Danish (da)

English (en)

Inventor

Malcolm Richard Smithklin Boyd

Original Assignee

Novartis Int Pharm Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-01-26

Filing date

1997-01-24

Publication date

2003-08-11

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10787583&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0876146(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1997-01-24 Application filed by Novartis Int Pharm Ltd filed Critical Novartis Int Pharm Ltd

2003-08-11 Application granted granted Critical

2003-08-11 Publication of DK0876146T3 publication Critical patent/DK0876146T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Virology (AREA)
Communicable Diseases (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biotechnology (AREA)
Molecular Biology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

DK97901694T 1996-01-26 1997-01-24 Nucleoside analoger i kombinationsterapi af herpes simplex infektioner DK0876146T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9601544.1A GB9601544D0 (en)	1996-01-26	1996-01-26	Pharmaceuticals
PCT/GB1997/000226 WO1997026882A1 (fr)	1996-01-26	1997-01-24	Analogues de nucleosides utilises dans une therapie combinee contre des infections dues a l'herpes simplex

Publications (1)

Publication Number	Publication Date
DK0876146T3 true DK0876146T3 (da)	2003-08-11

Family

ID=10787583

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK97901694T DK0876146T3 (da)	1996-01-26	1997-01-24	Nucleoside analoger i kombinationsterapi af herpes simplex infektioner

Country Status (25)

Country	Link
US (5)	US6514980B1 (fr)
EP (1)	EP0876146B1 (fr)
JP (1)	JP2000507211A (fr)
KR (1)	KR19990081966A (fr)
CN (1)	CN1133433C (fr)
AR (1)	AR005551A1 (fr)
AT (1)	ATE238796T1 (fr)
AU (1)	AU713202B2 (fr)
BR (1)	BR9707304A (fr)
CY (1)	CY2421B1 (fr)
CZ (1)	CZ297841B6 (fr)
DE (1)	DE69721484T2 (fr)
DK (1)	DK0876146T3 (fr)
ES (1)	ES2199339T3 (fr)
GB (1)	GB9601544D0 (fr)
HU (1)	HU226793B1 (fr)
IL (1)	IL125075A (fr)
NO (1)	NO316355B1 (fr)
NZ (1)	NZ326839A (fr)
PL (1)	PL187076B1 (fr)
PT (1)	PT876146E (fr)
TR (1)	TR199801439T2 (fr)
TW (1)	TW493985B (fr)
WO (1)	WO1997026882A1 (fr)
ZA (1)	ZA97608B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TW438585B (en)	1995-02-06	2001-06-07	Astra Ab	Pharmaceutical compositions for topical administration for prophylaxis and/or treatment of herpesvirus infections
GB9601544D0 (en) *	1996-01-26	1996-03-27	Smithkline Beecham Plc	Pharmaceuticals
US7591945B2 (en) *	2003-02-07	2009-09-22	Gambro Lundia Ab	Support device for containers in extracorporeal blood treatment machines
US7741296B2 (en) *	2005-03-25	2010-06-22	Bondarev Igor E	Modulation of telomere length in telomerase positive cells and cancer therapy
WO2006125166A2 (fr) *	2005-05-18	2006-11-23	Alt Solutions, Inc.	Modulation pharmacologique de la longueur telomerique dans des cellules cancereuses pour la prevention et le traitement de cancer
US20110065655A1 (en) *	2009-09-17	2011-03-17	Karry Whitten	Therapeutic composition to treat lesions caused by herpes simplex virus
GB201907305D0 (en) *	2019-05-23	2019-07-10	Douglas Pharmaceuticals Ltd	Treatment of conditions
CN112704154A (zh) *	2020-12-24	2021-04-27	中国人民解放军66399部队	一种用于治疗宠物猫疱疹病毒的营养膏

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3317384A (en) *	1964-06-08	1967-05-02	Upjohn Co	Treatment of topical viral infections with glucocorticoids and nucleosides
US3322627A (en) *	1964-09-03	1967-05-30	Merck & Co Inc	Method of treating herpes simplex infections with 5-methylamino-2'-deoxyuridine, and compositions therefor
GB9001886D0 (en) *	1990-01-26	1990-03-28	Beecham Group Plc	Pharmaceutical formulation
GB9015051D0 (en) *	1990-07-07	1990-08-29	Beecham Group Plc	Pharmaceutical treatment
DE69306545T2 (de)	1992-10-01	1997-04-03	Wellcome Found	Tucaresol als Mittel zur Immunopotentierung
GB9426021D0 (en)	1994-12-22	1995-02-22	Smithkline Beecham Plc	Pharmaceuticals
TW438585B (en) *	1995-02-06	2001-06-07	Astra Ab	Pharmaceutical compositions for topical administration for prophylaxis and/or treatment of herpesvirus infections
GB9601544D0 (en) *	1996-01-26	1996-03-27	Smithkline Beecham Plc	Pharmaceuticals
US6136835A (en) *	1999-05-17	2000-10-24	The Procter & Gamble Company	Methods of treatment for viral infections

1996
- 1996-01-26 GB GBGB9601544.1A patent/GB9601544D0/en active Pending
1997
- 1997-01-24 TR TR1998/01439T patent/TR199801439T2/xx unknown
- 1997-01-24 IL IL12507597A patent/IL125075A/xx not_active IP Right Cessation
- 1997-01-24 CZ CZ0234098A patent/CZ297841B6/cs not_active IP Right Cessation
- 1997-01-24 AT AT97901694T patent/ATE238796T1/de active
- 1997-01-24 DE DE69721484T patent/DE69721484T2/de not_active Expired - Fee Related
- 1997-01-24 WO PCT/GB1997/000226 patent/WO1997026882A1/fr not_active Ceased
- 1997-01-24 ZA ZA97608A patent/ZA97608B/xx unknown
- 1997-01-24 HU HU9900945A patent/HU226793B1/hu not_active IP Right Cessation
- 1997-01-24 PL PL97327917A patent/PL187076B1/pl not_active IP Right Cessation
- 1997-01-24 AU AU15506/97A patent/AU713202B2/en not_active Ceased
- 1997-01-24 JP JP9526681A patent/JP2000507211A/ja active Pending
- 1997-01-24 KR KR1019980705684A patent/KR19990081966A/ko not_active Ceased
- 1997-01-24 EP EP97901694A patent/EP0876146B1/fr not_active Revoked
- 1997-01-24 NZ NZ326839A patent/NZ326839A/en not_active IP Right Cessation
- 1997-01-24 CN CNB971918694A patent/CN1133433C/zh not_active Expired - Fee Related
- 1997-01-24 ES ES97901694T patent/ES2199339T3/es not_active Expired - Lifetime
- 1997-01-24 AR ARP970100303A patent/AR005551A1/es not_active Application Discontinuation
- 1997-01-24 BR BR9707304A patent/BR9707304A/pt not_active IP Right Cessation
- 1997-01-24 PT PT97901694T patent/PT876146E/pt unknown
- 1997-01-24 DK DK97901694T patent/DK0876146T3/da active
- 1997-02-26 TW TW086102357A patent/TW493985B/zh active
1998
- 1998-07-23 NO NO19983402A patent/NO316355B1/no not_active IP Right Cessation
2000
- 2000-07-26 US US09/626,015 patent/US6514980B1/en not_active Expired - Lifetime
2001
- 2001-06-19 US US09/884,715 patent/US20040185433A1/en not_active Abandoned
2004
- 2004-01-08 CY CY0400005A patent/CY2421B1/xx unknown
2005
- 2005-04-14 US US11/105,842 patent/US20050222016A1/en not_active Abandoned
2008
- 2008-07-02 US US12/217,193 patent/US20080287389A1/en not_active Abandoned
2010
- 2010-08-30 US US12/871,563 patent/US20100323952A1/en not_active Abandoned

Also Published As

Publication number	Publication date
US20100323952A1 (en)	2010-12-23
IL125075A (en)	2003-02-12
US6514980B1 (en)	2003-02-04
US20040185433A1 (en)	2004-09-23
CZ234098A3 (cs)	1999-02-17
NO316355B1 (no)	2004-01-19
BR9707304A (pt)	1999-07-20
KR19990081966A (ko)	1999-11-15
GB9601544D0 (en)	1996-03-27
EP0876146A1 (fr)	1998-11-11
HK1016475A1 (en)	1999-11-05
US20050222016A1 (en)	2005-10-06
DE69721484T2 (de)	2004-02-26
PL187076B1 (pl)	2004-05-31
AU713202B2 (en)	1999-11-25
CN1209748A (zh)	1999-03-03
ES2199339T3 (es)	2004-02-16
NO983402D0 (no)	1998-07-23
IL125075A0 (en)	1999-01-26
ATE238796T1 (de)	2003-05-15
DE69721484D1 (de)	2003-06-05
US20080287389A1 (en)	2008-11-20
HUP9900945A2 (hu)	1999-07-28
TW493985B (en)	2002-07-11
PL327917A1 (en)	1999-01-04
AU1550697A (en)	1997-08-20
HU226793B1 (en)	2009-10-28
ZA97608B (en)	1998-07-24
TR199801439T2 (xx)	1998-10-21
EP0876146B1 (fr)	2003-05-02
NZ326839A (en)	2001-02-23
AR005551A1 (es)	1999-06-23
CZ297841B6 (cs)	2007-04-11
NO983402L (no)	1998-07-23
CN1133433C (zh)	2004-01-07
CY2421B1 (en)	2004-11-12
HUP9900945A3 (en)	2001-02-28
PT876146E (pt)	2003-09-30
JP2000507211A (ja)	2000-06-13
WO1997026882A1 (fr)	1997-07-31

Publication	Publication Date	Title
CY2006008I2 (el)	2016-10-05	Hydroxymethyl (methylenecyclopentyl) purines and pyrimidines
DK1498124T3 (da)	2007-11-05	Anvendelse af inhibitorer i renin-angiotensinsystemet
FI944134L (fi)	1994-11-07	Virustenvastaisia nukleosidianalogeja
AP9300603A0 (en)	1994-01-31	Use of dideoxy nucleoside analogues in the treatment of viral infections
FI940167A0 (fi)	1994-01-13	Puriinijohdannaisia
DK0983271T3 (da)	2004-05-10	Carbocyklisk nucleosidhemisulfat og anvendelsen deraf i behandlingen af virusinfektioner
DK0876146T3 (da)	2003-08-11	Nucleoside analoger i kombinationsterapi af herpes simplex infektioner
FI953127A0 (fi)	1995-06-22	Puriinijohdannaisia
DK1140937T3 (da)	2004-03-22	Antivirale nucleosid-analoger
BR9509986A (pt)	1997-11-25	Uso de agentes antivirais aminopurina para o tratamento e profilaxia de infecções de vírus de herpes latentes
NO995620D0 (no)	1999-11-16	Antivirale kombinasjoner inneholdende karbocyklisk nukleosid 1592U89
BR9406575A (pt)	1996-03-19	Método de combater infecçoes virais de herpes simplex aciclovir-resistentes
FI964468A0 (fi)	1996-11-06	Adenosiinijohdannaisia
SI0876146T1 (en)	2004-02-29	Nucleoside analogs in combination therapy of herpes simplex infections
NO995621D0 (no)	1999-11-16	Antivirale kombinasjoner inneholdende karbocyklisk nukleoid 1592U89
FI956246L (fi)	1995-12-22	Hiili-asykliset nukleosidijohdannaiset antiviraalisina ja antineoplastisina aineina
DK0850246T3 (da)	2002-02-25	Pyrimidinnukleosidderivater
ID17477A (id)	1998-01-08	Turunan-turunan pirimidina nukleosida
ITCA950008A0 (it)	1995-06-13	Impiego di combinaqzioni di analoghi di nucleosidi nella terapia delleinfezioni dell'aids.
MX9102245A (es)	1992-07-08	Combinaciones de compuestos vainilloides y compuestos antivirales de nucleosido para el tratamiento de infecciones de herpes
ID17550A (id)	1998-01-08	Turunan nukleosida pirimidina
NO940123D0 (no)	1994-01-13	Purinderivater